Testing the Safety of Herbal Mosquitocidal Fumigant for Human use

Phase I Clinical Trial for Safety Assessment of an Innovative, Commercially Viable and Eco-Friendly Mosquitocidal Fumigant in Healthy Human Volunteers - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092498

Enrollment

Registered

2025-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Herbal mosquitocidal fumigant: Healthy human volunteers are exposed to fumes from ignited herbal fumigant for different time periods for assessing the safety and the data after 14 days

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers male and female, of the age group 18 to 45 years

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women. 2. Allergy or sensitivity to fumigants or similar compounds. 3. Recent participation in another clinical trial. 4. Smoking, alcohol, or substance abuse. 5. Those on any medication.

Design outcomes

Primary

Measure	Time frame
1. Assessing the safety of the herbal fumigant 2. Acceptance of the herbal fumigant in comparison to marketed productTimepoint: Analysis will be performed at 0 to 14 days of exposure to the herbal fumigant for different time intervals, i.e., 1hr, 2hr and 3hr.	—

Secondary

Measure	Time frame
The following blood parameters will be checked: 1. Haemoglobin 2. Blood Urea, Serum Creatinine 3. Serum electrolytes - Sodium, Potassium and Chloride 4. Serum Bilirubin 5. SGOT, SGPT, ALP Timepoint: Baseline at 0 day and after exposure for 14 days	—

Countries

India

Contacts

Public ContactMythili Krishna Jeedigunta

Gao Medical College

rataboli_padmanabh@rediffmail.com9822386263

Outcome results